Conor MacKay

With several readouts coming over the balance of the year, what are you looking to see from those readouts to get comfortable with your competitive positioning in the atopic dermatitis market?

can you maybe talk a bit about the lessons you've taken from those and then as well as sort of your experience early days in the Kisunla launch